Sabina Grossi
Directeur/Bestuurslid bij Fondazione Oliver Twist Onlus
Profiel
Sabina Grossi is currently the Director at Fondazione Oliver Twist Onlus.
Previously, she was the Chairman at Onesight Luxottica Group Foundation ONLUS from 2009 to 2012.
She also served as a Non-Executive Director at Luxottica Group SpA and an Independent Non-Executive Director at AGC Biologics SpA.
Ms. Grossi obtained an undergraduate degree from The LUISS University of Rome.
Actieve functies van Sabina Grossi
| Bedrijven | Functie | Begin |
|---|---|---|
| Fondazione Oliver Twist Onlus | Directeur/Bestuurslid | 15-01-2010 |
Eerdere bekende functies van Sabina Grossi
| Bedrijven | Functie | Einde |
|---|---|---|
| Onesight Luxottica Group Foundation ONLUS | Voorzitter | 01-01-2012 |
| LUXOTTICA GROUP | Directeur/Bestuurslid | - |
| MOLMED S.P.A. | Directeur/Bestuurslid | - |
Opleiding van Sabina Grossi
| The LUISS University of Rome | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Luxottica Group SpA
 Luxottica Group SpA Medical SpecialtiesHealth Technology Luxottica Group SpA engages in the designing, manufacturing, and distribution of fashion, luxury, sport, and performance eyewear. The company was founded by Leonardo del Vecchio in 1961 and is headquartered in Milan, Italy. | Health Technology |
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
| Fondazione Oliver Twist Onlus | |
| Onesight Luxottica Group Foundation ONLUS |
